Feed Preview

Immunotherapy (Preprints)

Immunotherapy (Preprints)   diagram by Carl Dupont, Shutterstock
Carl Dupont, Shutterstock

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest preprints on cancer immunotherapy here.

Top 20 most recent papers
bioRxiv

Sex-based mutational landscape confers sensitivity to checkpoint blockade immunotherapy in cutaneous melanoma

bioRxivDecember 8, 2019
Mingming Jia, Tian Chi
3
bioRxiv

Identification of human CD4+ T cell populations with distinct antitumor activity

bioRxivJanuary 2, 2020
Michelle H NelsonChrystal M Paulos
30
bioRxiv

Anti-PD-1 treatment as a neurotherapy to enhance neuronal excitability, synaptic plasticity and memory

bioRxivDecember 10, 2019
Junli Zhao, Ru Rong Ji
6
bioRxiv

Targeting dual signaling pathways in concert with immune checkpoints for the treatment of pancreatic cancer

bioRxivDecember 5, 2019
Erik KnudsenAgnieszka Witkiewicz
15
bioRxiv

Temporal and spatial modulation of the immune response of the murine Gl261 glioma tumor microenvironment

bioRxivNovember 28, 2019
Kelly J McKelveyViive M Howell
9
bioRxiv

Single-Cell Map of Diverse Immune Phenotypes in the Metastatic Brain Tumor Microenvironment of Non Small Cell Lung Cancer

bioRxivDecember 30, 2019
Liang WangWei-Lin Jin
9
bioRxiv

Interruption of thymic activity in adults improves responses to tumor immunotherapy

bioRxivJanuary 9, 2020
José Almeida-SantosJocelyne Demengeot
11
bioRxiv

A multifunctional R package for identification of tumor-specific neoantigens

bioRxivDecember 9, 2019
Takanori HasegawaSeiya Imoto
18
bioRxiv

Optimising DNA-Coated Gold Nanoparticles to Enrich Skeletal Stem Cells from Human Bone Marrow Samples

bioRxivDecember 19, 2019
S.A. LanhamR.O.C. Oreffo
5
bioRxiv

Dynamics of T cell activation mediated by eIF3 interactions with T cell receptor mRNAs

bioRxivDecember 21, 2019
Dasmanthie De SilvaJamie H. D. Cate
28
bioRxiv

The dynamic surface proteomes of allergenic fungal conidia

bioRxivJanuary 11, 2020
Matthew G. BlangoAxel A. Brakhage
19
bioRxiv

In Vitro Platform Establishes Antigen-Specific CD8+ T Cell Cytotoxicity to Encapsulated Cells via Indirect Antigen Recognition

bioRxivDecember 12, 2019
Ying LiCherie L. Stabler
8
bioRxiv

Transfer of antigen-encoding bone marrow under immune-preserving conditions deletes mature antigen-specific B cells in recipients and inhibits antigen-specific antibody production

bioRxivDecember 21, 2019
Jeremy F BrooksRaymond J Steptoe
15
bioRxiv

Neutralizing PD-L1 and PD-L2 Enhances the Efficacy of Immune Checkpoint Inhibitors in Ovarian Cancer.

bioRxivJanuary 20, 2020
Yu Rebecca MiaoAmato J. Giaccia
bioRxiv

Hominini-Specific Regulation of CBLN2 Increases Prefrontal Synaptogenesis

bioRxivDecember 31, 2019
Mikihito ShibataNenad Sestan
7
bioRxiv

Rewired signaling network in T cells expressing the chimeric antigen receptor (CAR)

bioRxivDecember 20, 2019
Rui DongXiaolei Su
8
bioRxiv

Antibody Bank: the Synthetic Cell Repertoire for Immunotherapy

bioRxivDecember 8, 2019
Wenyan FuShi Hu
2
bioRxiv

OvirusTdb: A Repository of Oncolytic Viruses used in Cancer Treatment

bioRxivJanuary 9, 2020
Anjali LathwalGajendra P.S. Raghava
6
bioRxiv

CrkL is required for donor T cell migration to GvHD Target organs

bioRxivNovember 25, 2019
Nathan H RoyMobin Karimi
16
bioRxiv

Small molecule inhibitors and a kinase-dead expressing mouse model demonstrate that the kinase activity of Chk1 is essential for mouse embryos and cancer cells

bioRxivJanuary 21, 2020
Somsundar V MuralidharanJonas A Nilsson

See more papers from this feed

Related Feeds

© 2020 Meta ULC. All rights reserved
/feed-previews/immunotherapy-preprints/ff266c47-e266-4966-9c1e-c7e480abb2f9